Provided by: Chunghwa Chemical Synthesis & Biotech Co.,Ltd
SEQ_NO
10
Date of announcement
2022/05/25
Time of announcement
17:48:55
Subject
Reelection of the company chairman.
Date of events
2022/05/25
To which item it meets
paragraph 6
Statement
1.Date of the board of directors resolution or date of occurrence of the
change:2022/05/25
2.Position (Please enter chairperson or president/general manager):
chairperson
3.Name of the previous position holder:
Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./
WANG HSIEH YI-CHEN
4.Resume of the previous position holder:
Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./
WANG HSIEH YI-CHEN/ The company Chairman
5.Name of the new position holder:
Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./
WANG HSIEH YI-CHEN
6.Resume of the new position holder:
Representative of CHINA CHEMICAL & PHARMACEUTICAL CO., LTD./
WANG HSIEH YI-CHEN/ The company Chairman
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired" , "job relocation", "severance", "retirement",
"death" or "new appointment"):term expired
8.Reason for the change:Tenure expired,Re-election of directors
9.Effective date of the new appointment:2022/05/25
10.Any other matters that need to be specified:None
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chunghwa Chemical Synthesis & Biotech Co. Ltd. published this content on 25 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2022 16:12:02 UTC.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. 
